Tarsus Pharmaceuticals is making a splash with Xdemvy, an eye drop that kills the demodex mites that cause inflammation and ...

IRVINE, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ: TARS), today announced that management will participate in ...

One common condition linked to excess Demodex is rosacea, which causes facial redness and inflammation. Studies have found higher numbers of these mites in the same areas affected by rosacea, but it’s ...

If you've ever suffered from common skin conditions like rosacea, eczema or psoriasis, you know how uncomfortable the itching, irritation and redness can be. Fortunately, you don't have to suffer in ...

Demodex brevis is a microscopic mite that lives in the oil glands of human hair follicles. It’s typically found on the face but can also live on other parts of the body. Demodex brevis is a type ...

And after trying approximately 47,000 products that promised to fix my rosacea (spoiler alert: they didn't), I've finally found something that actually works. No, I'm not being dramatic (for once). If ...

Moreover, Tarsus is extending its reach into ocular rosacea, a condition with no FDA ... is a novel drug that targets the Demodex mite nervous system to kill the mites. Read More on TARS: Tarsus ...